Investment Director, Life Sciences, Bpifrance Investissements
Since 2014 at Bpifrance Investissements, Benoit has been involved in a dozen investment deals and current board member positions include Alentis, Dynacure, Igyxos, Meiogenix and BrainEver. Prior to this, he gained experience in various biotech roles, co-discovered a vaccine candidate, and developed an antibody production service. He holds an MSc in Biotechnology Engineering from the University of Technology of Compiègne (UTC), a PhD in immunology from the University of Nantes and an executive Master in Finance from the Sorbonne Business School.